How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Establishing the budget for the United States Government for fiscal year 2014 and setting forth appropriate budgetary levels for fiscal years 2015 through 2023.
Client: NOVO NORDISK INC. · Firm: NOVO NORDISK INC.
Issues related to Medicare Part D, FDA and patents in S. Con. Res. 8 FY14 Senate Budget Resolution; H Con Res. 25 House Budget Resolution; Modernizing cost estimates with respect to preventive health legislation (CBO scoring); National Diabetes Prevention Program; HR 933 -- Consolidated and Further Continuing Appropriations Act, 2013
Establishing the budget for the United States Government for fiscal year 2014 and setting forth appropriate budgetary levels for fiscal years 2015 through 2023.
Client: NOVO NORDISK INC. · Firm:
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
NOVO NORDISK INC. via NOVO NORDISK INC.
2013 · second_quarter · Q2
H.R. 8 American Taxpayer Relief Act (R&D tax credit) of 2012 (R&D credit); H.R. 2052 and S. 1023 Global Investment in American Jobs Act
H.R. 962 and S. 452 Medicare Diabetes Prevention Act of 2013; Issues related to Medicare Part D and Medicaid rebates as contained in P.L. 112-25 Budget Control Act of 2011, H.R. 8 American Taxpayer Relief Actof 2012, and H.R. 1588 and S. 740 Medicare Drug Savings Act of 2013; H.R. 1257 Preventing Diabetes in Medicare Act of 2013 and prediabetes generally; H.R. 1274 and S. 945 Access to Quality Diabetes Education Act of 2013 (Diabetes Self-Management Training in Medicare);Medicare diabetes screening generally; S. 1184 and H.R. 2415 Treat and Reduce Obesity Act of 2013; Physician Quality and Reporting System (PQRS)
Source: Senate LDA
Issues related to Medicare Part D, FDA and patents in S. Con. Res. 8 FY14 Senate Budget Resolution; H. Con. Res. 25 House Budget Resolution; H.R. 2663 The Preventative Health Savings Act of 2013 (Modernizing CBO scoring estimates with respect to preventive health legislation); National Diabetes Prevention Program in H.R. 933 -- FY13 Consolidated and Further Continuing Appropriations Act and S. 1284 FY14 Depts. of Labor, Health and Human Services, and Education Appropriations Act
National Diabetes Clinical Care Commission Act
Client: NOVO NORDISK INC. · Firm: NOVO NORDISK INC.
National Diabetes Prevention Program; Better care and treatment of people with diabetes under P.L. 111-148 Patient Protection and Affordable Care Act of 2009 (ACA) and P.L. 111-152 The Health Care & Education Affordability Reconciliation Act of 2010: Issues related to diabetes generally, and specifically diabetes screening, medical education and death certificate reporting (Catalyst for Better Diabetes), Prevention and Public Health Fund, AHRQ and USPSTF diabetes screening standards;diabetes issues in Healthy People 2020 and the Office of Disease Prevention and Health Promotion (ODPHP); H.R. 1074 and S 539 National Diabetes Clinical Care Commission Act of 2013; human growth / rare disorders awareness; H.R. 8 American Taxpayer Relief Act (Special Diabetes Program reauthorization); gestational diabetes; diabetes disparities; H.R. 351 and S. 351 Protecting Seniors' Access to Medicare Act of 2013 (IPAB repeal)
National Diabetes Clinical Care Commission Act
Client: NOVO NORDISK INC. · Firm: NOVO NORDISK INC.
National Diabetes Prevention Program; Better care and treatment of people with diabetes under P.L. 111-148 Patient Protection and Affordable Care Act of 2009 (ACA) and P.L. 111-152 The Health Care & Education Affordability Reconciliation Act of 2010: Issues related to diabetes generally, and specifically diabetes screening, medical education and death certificate reporting (Catalyst for Better Diabetes), Prevention and Public Health Fund, AHRQ and USPSTF diabetes screening standards;diabetes issues in Healthy People 2020 and the Office of Disease Prevention and Health Promotion (ODPHP); H.R. 1074 and S. 539 National Diabetes Clinical Care Commission Act of 2013; human growth / rare disorders awareness; H.R. 8 American Taxpayer Relief Act (Special Diabetes Program reauthorization); gestational diabetes; diabetes disparities; H.R. 351 and S. 351 Protecting Seniors' Access to Medicare Act of 2013 (IPAB repeal)
Preventing Diabetes in Medicare Act of 2013
Client: NOVO NORDISK INC. · Firm: NOVO NORDISK INC.
Issues related to Medicare Part D and Medicaid rebates as contained in P.L. 112-25 Budget Control Act of 2011 and H.R. 8 American Taxpayer Relief Actof 2012; H.R. 962 and S. 452 Medicare Diabetes Prevention Act of 2013; H.R. 1257 Preventing Diabetes in Medicare Act of 2013 and prediabetes generally; H.R. 1274 Access to Quality Diabetes Education Act of 2013 (Diabetes Self-Management Training in Medicare); Medicare diabetes screening generally
Preventing Diabetes in Medicare Act of 2013
Client: NOVO NORDISK INC. · Firm: NOVO NORDISK INC.
H.R. 962 and S. 452 Medicare Diabetes Prevention Act of 2013; Issues related to Medicare Part D and Medicaid rebates as contained in P.L. 112-25 Budget Control Act of 2011, H.R. 8 American Taxpayer Relief Actof 2012, and H.R. 1588 and S. 740 Medicare Drug Savings Act of 2013; H.R. 1257 Preventing Diabetes in Medicare Act of 2013 and prediabetes generally; H.R. 1274 and S. 945 Access to Quality Diabetes Education Act of 2013 (Diabetes Self-Management Training in Medicare);Medicare diabetes screening generally; S. 1184 and H.R. 2415 Treat and Reduce Obesity Act of 2013; Physician Quality and Reporting System (PQRS)
Access to Quality Diabetes Education Act of 2013
Client: NOVO NORDISK INC. · Firm: NOVO NORDISK INC.
H.R. 962 and S. 452 Medicare Diabetes Prevention Act of 2013; Issues related to Medicare Part D and Medicaid rebates as contained in P.L. 112-25 Budget Control Act of 2011, H.R. 8 American Taxpayer Relief Actof 2012, and H.R. 1588 and S. 740 Medicare Drug Savings Act of 2013; H.R. 1257 Preventing Diabetes in Medicare Act of 2013 and prediabetes generally; H.R. 1274 and S. 945 Access to Quality Diabetes Education Act of 2013 (Diabetes Self-Management Training in Medicare);Medicare diabetes screening generally; S. 1184 and H.R. 2415 Treat and Reduce Obesity Act of 2013; Physician Quality and Reporting System (PQRS)
Access to Quality Diabetes Education Act of 2013
Client: NOVO NORDISK INC. · Firm: NOVO NORDISK INC.
Issues related to Medicare Part D and Medicaid rebates as contained in P.L. 112-25 Budget Control Act of 2011 and H.R. 8 American Taxpayer Relief Actof 2012; H.R. 962 and S. 452 Medicare Diabetes Prevention Act of 2013; H.R. 1257 Preventing Diabetes in Medicare Act of 2013 and prediabetes generally; H.R. 1274 Access to Quality Diabetes Education Act of 2013 (Diabetes Self-Management Training in Medicare); Medicare diabetes screening generally
H.R. 962 and S. 452 Medicare Diabetes Prevention Act of 2013; Issues related to Medicare Part D and Medicaid rebates as contained in P.L. 112-25 Budget Control Act of 2011, H.R. 8 American Taxpayer Relief Actof 2012, and H.R. 1588 and S. 740 Medicare Drug Savings Act of 2013; H.R. 1257 Preventing Diabetes in Medicare Act of 2013 and prediabetes generally; H.R. 1274 and S. 945 Access to Quality Diabetes Education Act of 2013 (Diabetes Self-Management Training in Medicare);Medicare diabetes screening generally; S. 1184 and H.R. 2415 Treat and Reduce Obesity Act of 2013; Physician Quality and Reporting System (PQRS)
Safeguarding America's Pharmaceuticals Act of 2013
Client: NOVO NORDISK INC. · Firm: NOVO NORDISK INC.
H.R.1919 Safeguarding America's Pharmaceuticals Act of 2013 and S.959 Pharmaceutical Compounding Quality and Accountability Act (for track and trace supply chain provisions); issues regarding biosimilars; 340B
Global Investment in American Jobs Act of 2013
Client: NOVO NORDISK INC. · Firm: NOVO NORDISK INC.
H.R. 8 American Taxpayer Relief Act (R&D tax credit) of 2012 (R&D credit); H.R. 2052 and S. 1023 Global Investment in American Jobs Act
H.R. 962 and S. 452 Medicare Diabetes Prevention Act of 2013; Issues related to Medicare Part D and Medicaid rebates as contained in P.L. 112-25 Budget Control Act of 2011, H.R. 8 American Taxpayer Relief Actof 2012, and H.R. 1588 and S. 740 Medicare Drug Savings Act of 2013; H.R. 1257 Preventing Diabetes in Medicare Act of 2013 and prediabetes generally; H.R. 1274 and S. 945 Access to Quality Diabetes Education Act of 2013 (Diabetes Self-Management Training in Medicare);Medicare diabetes screening generally; S. 1184 and H.R. 2415 Treat and Reduce Obesity Act of 2013; Physician Quality and Reporting System (PQRS)
To amend the Congressional Budget Act of 1974 respecting the scoring of preventive health savings.
Client: NOVO NORDISK INC. · Firm: NOVO NORDISK INC.
Issues related to Medicare Part D, FDA and patents in S. Con. Res. 8 FY14 Senate Budget Resolution; H. Con. Res. 25 House Budget Resolution; H.R. 2663 The Preventative Health Savings Act of 2013 (Modernizing CBO scoring estimates with respect to preventive health legislation); National Diabetes Prevention Program in H.R. 933 -- FY13 Consolidated and Further Continuing Appropriations Act and S. 1284 FY14 Depts. of Labor, Health and Human Services, and Education Appropriations Act
Protecting Seniors' Access to Medicare Act of 2013
Client: NOVO NORDISK INC. · Firm: NOVO NORDISK INC.
National Diabetes Prevention Program; Better care and treatment of people with diabetes under P.L. 111-148 Patient Protection and Affordable Care Act of 2009 (ACA) and P.L. 111-152 The Health Care & Education Affordability Reconciliation Act of 2010: Issues related to diabetes generally, and specifically diabetes screening, medical education and death certificate reporting (Catalyst for Better Diabetes), Prevention and Public Health Fund, AHRQ and USPSTF diabetes screening standards;diabetes issues in Healthy People 2020 and the Office of Disease Prevention and Health Promotion (ODPHP); H.R. 1074 and S 539 National Diabetes Clinical Care Commission Act of 2013; human growth / rare disorders awareness; H.R. 8 American Taxpayer Relief Act (Special Diabetes Program reauthorization); gestational diabetes; diabetes disparities; H.R. 351 and S. 351 Protecting Seniors' Access to Medicare Act of 2013 (IPAB repeal)
Protecting Seniors' Access to Medicare Act of 2013
Client: NOVO NORDISK INC. · Firm: NOVO NORDISK INC.
National Diabetes Prevention Program; Better care and treatment of people with diabetes under P.L. 111-148 Patient Protection and Affordable Care Act of 2009 (ACA) and P.L. 111-152 The Health Care & Education Affordability Reconciliation Act of 2010: Issues related to diabetes generally, and specifically diabetes screening, medical education and death certificate reporting (Catalyst for Better Diabetes), Prevention and Public Health Fund, AHRQ and USPSTF diabetes screening standards;diabetes issues in Healthy People 2020 and the Office of Disease Prevention and Health Promotion (ODPHP); H.R. 1074 and S. 539 National Diabetes Clinical Care Commission Act of 2013; human growth / rare disorders awareness; H.R. 8 American Taxpayer Relief Act (Special Diabetes Program reauthorization); gestational diabetes; diabetes disparities; H.R. 351 and S. 351 Protecting Seniors' Access to Medicare Act of 2013 (IPAB repeal)
H.R. 962 and S. 452 Medicare Diabetes Prevention Act of 2013; Issues related to Medicare Part D and Medicaid rebates as contained in P.L. 112-25 Budget Control Act of 2011, H.R. 8 American Taxpayer Relief Actof 2012, and H.R. 1588 and S. 740 Medicare Drug Savings Act of 2013; H.R. 1257 Preventing Diabetes in Medicare Act of 2013 and prediabetes generally; H.R. 1274 and S. 945 Access to Quality Diabetes Education Act of 2013 (Diabetes Self-Management Training in Medicare);Medicare diabetes screening generally; S. 1184 and H.R. 2415 Treat and Reduce Obesity Act of 2013; Physician Quality and Reporting System (PQRS)
Issues related to Medicare Part D and Medicaid rebates as contained in P.L. 112-25 Budget Control Act of 2011 and H.R. 8 American Taxpayer Relief Actof 2012; H.R. 962 and S. 452 Medicare Diabetes Prevention Act of 2013; H.R. 1257 Preventing Diabetes in Medicare Act of 2013 and prediabetes generally; H.R. 1274 Access to Quality Diabetes Education Act of 2013 (Diabetes Self-Management Training in Medicare); Medicare diabetes screening generally
Global Investment in American Jobs Act of 2013
Client: NOVO NORDISK INC. · Firm: NOVO NORDISK INC.
H.R. 8 American Taxpayer Relief Act (R&D tax credit) of 2012 (R&D credit); H.R. 2052 and S. 1023 Global Investment in American Jobs Act
H.R. 962 and S. 452 Medicare Diabetes Prevention Act of 2013; Issues related to Medicare Part D and Medicaid rebates as contained in P.L. 112-25 Budget Control Act of 2011, H.R. 8 American Taxpayer Relief Actof 2012, and H.R. 1588 and S. 740 Medicare Drug Savings Act of 2013; H.R. 1257 Preventing Diabetes in Medicare Act of 2013 and prediabetes generally; H.R. 1274 and S. 945 Access to Quality Diabetes Education Act of 2013 (Diabetes Self-Management Training in Medicare);Medicare diabetes screening generally; S. 1184 and H.R. 2415 Treat and Reduce Obesity Act of 2013; Physician Quality and Reporting System (PQRS)
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2014
Client: NOVO NORDISK INC. · Firm: NOVO NORDISK INC.
Issues related to Medicare Part D, FDA and patents in S. Con. Res. 8 FY14 Senate Budget Resolution; H. Con. Res. 25 House Budget Resolution; H.R. 2663 The Preventative Health Savings Act of 2013 (Modernizing CBO scoring estimates with respect to preventive health legislation); National Diabetes Prevention Program in H.R. 933 -- FY13 Consolidated and Further Continuing Appropriations Act and S. 1284 FY14 Depts. of Labor, Health and Human Services, and Education Appropriations Act
Protecting Seniors' Access to Medicare Act of 2013
Client: NOVO NORDISK INC. · Firm: NOVO NORDISK INC.
National Diabetes Prevention Program; Better care and treatment of people with diabetes under P.L. 111-148 Patient Protection and Affordable Care Act of 2009 (ACA) and P.L. 111-152 The Health Care & Education Affordability Reconciliation Act of 2010: Issues related to diabetes generally, and specifically diabetes screening, medical education and death certificate reporting (Catalyst for Better Diabetes), Prevention and Public Health Fund, AHRQ and USPSTF diabetes screening standards;diabetes issues in Healthy People 2020 and the Office of Disease Prevention and Health Promotion (ODPHP); H.R. 1074 and S 539 National Diabetes Clinical Care Commission Act of 2013; human growth / rare disorders awareness; H.R. 8 American Taxpayer Relief Act (Special Diabetes Program reauthorization); gestational diabetes; diabetes disparities; H.R. 351 and S. 351 Protecting Seniors' Access to Medicare Act of 2013 (IPAB repeal)
Protecting Seniors' Access to Medicare Act of 2013
Client: NOVO NORDISK INC. · Firm: NOVO NORDISK INC.
National Diabetes Prevention Program; Better care and treatment of people with diabetes under P.L. 111-148 Patient Protection and Affordable Care Act of 2009 (ACA) and P.L. 111-152 The Health Care & Education Affordability Reconciliation Act of 2010: Issues related to diabetes generally, and specifically diabetes screening, medical education and death certificate reporting (Catalyst for Better Diabetes), Prevention and Public Health Fund, AHRQ and USPSTF diabetes screening standards;diabetes issues in Healthy People 2020 and the Office of Disease Prevention and Health Promotion (ODPHP); H.R. 1074 and S. 539 National Diabetes Clinical Care Commission Act of 2013; human growth / rare disorders awareness; H.R. 8 American Taxpayer Relief Act (Special Diabetes Program reauthorization); gestational diabetes; diabetes disparities; H.R. 351 and S. 351 Protecting Seniors' Access to Medicare Act of 2013 (IPAB repeal)
H.R. 962 and S. 452 Medicare Diabetes Prevention Act of 2013; Issues related to Medicare Part D and Medicaid rebates as contained in P.L. 112-25 Budget Control Act of 2011, H.R. 8 American Taxpayer Relief Actof 2012, and H.R. 1588 and S. 740 Medicare Drug Savings Act of 2013; H.R. 1257 Preventing Diabetes in Medicare Act of 2013 and prediabetes generally; H.R. 1274 and S. 945 Access to Quality Diabetes Education Act of 2013 (Diabetes Self-Management Training in Medicare);Medicare diabetes screening generally; S. 1184 and H.R. 2415 Treat and Reduce Obesity Act of 2013; Physician Quality and Reporting System (PQRS)
Issues related to Medicare Part D and Medicaid rebates as contained in P.L. 112-25 Budget Control Act of 2011 and H.R. 8 American Taxpayer Relief Actof 2012; H.R. 962 and S. 452 Medicare Diabetes Prevention Act of 2013; H.R. 1257 Preventing Diabetes in Medicare Act of 2013 and prediabetes generally; H.R. 1274 Access to Quality Diabetes Education Act of 2013 (Diabetes Self-Management Training in Medicare); Medicare diabetes screening generally
National Diabetes Clinical Care Commission Act
Client: NOVO NORDISK INC. · Firm: NOVO NORDISK INC.
National Diabetes Prevention Program; Better care and treatment of people with diabetes under P.L. 111-148 Patient Protection and Affordable Care Act of 2009 (ACA) and P.L. 111-152 The Health Care & Education Affordability Reconciliation Act of 2010: Issues related to diabetes generally, and specifically diabetes screening, medical education and death certificate reporting (Catalyst for Better Diabetes), Prevention and Public Health Fund, AHRQ and USPSTF diabetes screening standards;diabetes issues in Healthy People 2020 and the Office of Disease Prevention and Health Promotion (ODPHP); H.R. 1074 and S. 539 National Diabetes Clinical Care Commission Act of 2013; human growth / rare disorders awareness; H.R. 8 American Taxpayer Relief Act (Special Diabetes Program reauthorization); gestational diabetes; diabetes disparities; H.R. 351 and S. 351 Protecting Seniors' Access to Medicare Act of 2013 (IPAB repeal)
National Diabetes Clinical Care Commission Act
Client: NOVO NORDISK INC. · Firm: NOVO NORDISK INC.
National Diabetes Prevention Program; Better care and treatment of people with diabetes under P.L. 111-148 Patient Protection and Affordable Care Act of 2009 (ACA) and P.L. 111-152 The Health Care & Education Affordability Reconciliation Act of 2010: Issues related to diabetes generally, and specifically diabetes screening, medical education and death certificate reporting (Catalyst for Better Diabetes), Prevention and Public Health Fund, AHRQ and USPSTF diabetes screening standards;diabetes issues in Healthy People 2020 and the Office of Disease Prevention and Health Promotion (ODPHP); H.R. 1074 and S 539 National Diabetes Clinical Care Commission Act of 2013; human growth / rare disorders awareness; H.R. 8 American Taxpayer Relief Act (Special Diabetes Program reauthorization); gestational diabetes; diabetes disparities; H.R. 351 and S. 351 Protecting Seniors' Access to Medicare Act of 2013 (IPAB repeal)
Animal Drug and Animal Generic Drug User Fee Reauthorization Act of 2013
Client: NOVO NORDISK INC. · Firm: NOVO NORDISK INC.
Issues regarding Pharmaceutical Traceability Enhancement Code (Rx TEC) Act and discussion draft on serialization (track and trace); S.622 -- Animal Drug and Animal Generic Drug User Fee Reauthorization Act of 2013 for amendments that would impact human drug user fees; issues regarding biosimilars; 340B
H.R. 962 and S. 452 Medicare Diabetes Prevention Act of 2013; Issues related to Medicare Part D and Medicaid rebates as contained in P.L. 112-25 Budget Control Act of 2011, H.R. 8 American Taxpayer Relief Actof 2012, and H.R. 1588 and S. 740 Medicare Drug Savings Act of 2013; H.R. 1257 Preventing Diabetes in Medicare Act of 2013 and prediabetes generally; H.R. 1274 and S. 945 Access to Quality Diabetes Education Act of 2013 (Diabetes Self-Management Training in Medicare);Medicare diabetes screening generally; S. 1184 and H.R. 2415 Treat and Reduce Obesity Act of 2013; Physician Quality and Reporting System (PQRS)
Access to Quality Diabetes Education Act of 2013
Client: NOVO NORDISK INC. · Firm: NOVO NORDISK INC.
H.R. 962 and S. 452 Medicare Diabetes Prevention Act of 2013; Issues related to Medicare Part D and Medicaid rebates as contained in P.L. 112-25 Budget Control Act of 2011, H.R. 8 American Taxpayer Relief Actof 2012, and H.R. 1588 and S. 740 Medicare Drug Savings Act of 2013; H.R. 1257 Preventing Diabetes in Medicare Act of 2013 and prediabetes generally; H.R. 1274 and S. 945 Access to Quality Diabetes Education Act of 2013 (Diabetes Self-Management Training in Medicare);Medicare diabetes screening generally; S. 1184 and H.R. 2415 Treat and Reduce Obesity Act of 2013; Physician Quality and Reporting System (PQRS)
Pharmaceutical Quality, Security, and Accountability Act
Client: NOVO NORDISK INC. · Firm: NOVO NORDISK INC.
H.R.1919 Safeguarding America's Pharmaceuticals Act of 2013 and S.959 Pharmaceutical Compounding Quality and Accountability Act (for track and trace supply chain provisions); issues regarding biosimilars; 340B
National Diabetes Prevention Program; Better care and treatment of people with diabetes under P.L. 111-148 Patient Protection and Affordable Care Act of 2009 (ACA) and P.L. 111-152 The Health Care & Education Affordability Reconciliation Act of 2010: Issues related to diabetes generally, and specifically diabetes screening, medical education and death certificate reporting (Catalyst for Better Diabetes), Prevention and Public Health Fund, AHRQ and USPSTF diabetes screening standards;diabetes issues in Healthy People 2020 and the Office of Disease Prevention and Health Promotion (ODPHP); H.R. 1074 and S 539 National Diabetes Clinical Care Commission Act of 2013; human growth / rare disorders awareness; H.R. 8 American Taxpayer Relief Act (Special Diabetes Program reauthorization); gestational diabetes; diabetes disparities; H.R. 351 and S. 351 Protecting Seniors' Access to Medicare Act of 2013 (IPAB repeal)
Issues related to Medicare Part D and Medicaid rebates as contained in P.L. 112-25 Budget Control Act of 2011 and H.R. 8 American Taxpayer Relief Actof 2012; H.R. 962 and S. 452 Medicare Diabetes Prevention Act of 2013; H.R. 1257 Preventing Diabetes in Medicare Act of 2013 and prediabetes generally; H.R. 1274 Access to Quality Diabetes Education Act of 2013 (Diabetes Self-Management Training in Medicare); Medicare diabetes screening generally
H.R. 962 and S. 452 Medicare Diabetes Prevention Act of 2013; Issues related to Medicare Part D and Medicaid rebates as contained in P.L. 112-25 Budget Control Act of 2011, H.R. 8 American Taxpayer Relief Actof 2012, and H.R. 1588 and S. 740 Medicare Drug Savings Act of 2013; H.R. 1257 Preventing Diabetes in Medicare Act of 2013 and prediabetes generally; H.R. 1274 and S. 945 Access to Quality Diabetes Education Act of 2013 (Diabetes Self-Management Training in Medicare);Medicare diabetes screening generally; S. 1184 and H.R. 2415 Treat and Reduce Obesity Act of 2013; Physician Quality and Reporting System (PQRS)
HR 8 American Taxpayer Relief Act (R&D tax credit) of 2012 (R&D credit)
H.R. 8 American Taxpayer Relief Act (R&D tax credit) of 2012 (R&D credit); H.R. 2052 and S. 1023 Global Investment in American Jobs Act
National Diabetes Prevention Program; Better care and treatment of people with diabetes under P.L. 111-148 Patient Protection and Affordable Care Act of 2009 (ACA) and P.L. 111-152 The Health Care & Education Affordability Reconciliation Act of 2010: Issues related to diabetes generally, and specifically diabetes screening, medical education and death certificate reporting (Catalyst for Better Diabetes), Prevention and Public Health Fund, AHRQ and USPSTF diabetes screening standards;diabetes issues in Healthy People 2020 and the Office of Disease Prevention and Health Promotion (ODPHP); H.R. 1074 and S. 539 National Diabetes Clinical Care Commission Act of 2013; human growth / rare disorders awareness; H.R. 8 American Taxpayer Relief Act (Special Diabetes Program reauthorization); gestational diabetes; diabetes disparities; H.R. 351 and S. 351 Protecting Seniors' Access to Medicare Act of 2013 (IPAB repeal)
A concurrent resolution expressing support for Children's Dental Health Month and honoring the memory of Deamonte Driver.
Client: NOVO NORDISK INC. · Firm: NOVO NORDISK INC.
Issues related to Medicare Part D, FDA and patents in S. Con. Res. 8 FY14 Senate Budget Resolution; H Con Res. 25 House Budget Resolution; Modernizing cost estimates with respect to preventive health legislation (CBO scoring); National Diabetes Prevention Program; HR 933 -- Consolidated and Further Continuing Appropriations Act, 2013
A concurrent resolution expressing support for Children's Dental Health Month and honoring the memory of Deamonte Driver.
Client: NOVO NORDISK INC. · Firm: NOVO NORDISK INC.
Issues related to Medicare Part D, FDA and patents in S. Con. Res. 8 FY14 Senate Budget Resolution; H. Con. Res. 25 House Budget Resolution; H.R. 2663 The Preventative Health Savings Act of 2013 (Modernizing CBO scoring estimates with respect to preventive health legislation); National Diabetes Prevention Program in H.R. 933 -- FY13 Consolidated and Further Continuing Appropriations Act and S. 1284 FY14 Depts. of Labor, Health and Human Services, and Education Appropriations Act
Great Ape Protection and Cost Savings Act of 2011
Client: NOVO NORDISK INC. · Firm: NOVO NORDISK INC.
P.L. 111-148, Patient Protection and Affordable Care Act of 2009 (ACA) and P.L. 111-152, The Health Care & Education Affordability Reconciliation Act of 2010: Issues regarding comparative effectiveness, implementation of Physician Payment Sunshine provisions and Prescription Drug Sample reporting provisions; S.3187 FDA Safety and Innovation Act; H.R. 4274 Best Pharmaceuticals for Children Act/Pediatric Research Exclusivity Act; H.R. 3026 Safeguarding America's Pharmaceuticals Act of 2011; Pharmaceutical Traceability Enhancement Code (Rx TEC) Act and draft legislation on downstream supply chain safety/serialization; H.R. 5973 FY2013 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act (FDA funding); 340B; HR 1513 / S 810 Great Apes Protection Act
FY12 Budget Resolution and FY13 Appropriations: diabetes-related issues and issues related to modernizing cost estimates with respect to preventive health legislation and National Diabetes Prevention Program HR 2608 (PL 112-36) Continuing Appropriations Act, 2012; HJ RES 94 (PL 112-67); CR through 12/17/11; HJ RES 95 (PL 112-68) CR through 12/23/11; P.L. 112-74 Consolidated Appropriations Act of 2012 on National Diabetes Prevention Program
Preventing Diabetes in Medicare Act of 2011
Client: NOVO NORDISK INC. · Firm: NOVO NORDISK INC.
P.L. 111-148, Patient Protection and Affordable Care Act of 2009 (ACA) and P.L. 111-152, The Health Care & Education Affordability Reconciliation Act of 2010; CMS Proposed Coverage Decision Memorandum for Intensive Behavioral Therapy for Obesity; Medicare Diabetes Screening; HR 2741, Preventing Diabetes in Medicare Act of 2011 and Prediabetes generally; Medicaid coverage of obesity counseling and expanding provider type; Issues related to Medicare Part D and Medicaid rebates as contained in P.L. 112-25 Budget Control Act of 2011 (deficit reduction)
Preventing Diabetes in Medicare Act of 2011
Client: NOVO NORDISK INC. · Firm: NOVO NORDISK INC.
P.L. 111-148, Patient Protection and Affordable Care Act of 2009 (ACA) and P.L. 111-152, The Health Care & Education Affordability Reconciliation Act of 2010; CMS Proposed Coverage Decision Memorandum for Intensive Behavioral Therapy for Obesity; Medicare Diabetes Screening; HR 2741, Preventing Diabetes in Medicare Act of 2011 and Prediabetes generally; Issues related to Medicaid rebates and similar revenue provisions as contained in P.L. 112-25, Budget Control Act of 2011 (deficit reduction); HR 3743 Middle Class Tax Relief and Job Creation Act of 2011, HR 3630 Middle Class Tax Relief and Job Creation Act of 2011, and HR 3765 (PL 112-78) Temporary Payroll Tax Cut Continuation of 2011-Issues related to Medicaid rebates and similar revenue provisions; Medicaid coverage of obesity counseling and expanding provider type.
Preventing Diabetes in Medicare Act of 2011
Client: NOVO NORDISK INC. · Firm: NOVO NORDISK INC.
P.L. 111-148, Patient Protection and Affordable Care Act of 2009 (ACA) and P.L. 111-152, The Health Care & Education Affordability Reconciliation Act of 2010; CMS Proposed Coverage Decision Memorandum for Intensive Behavioral Therapy for Obesity; Medicare Diabetes Screening; HR 6548 Medicare Diabetes Prevention Act of 2012; S 3463 Medicare Diabetes Prevention Act of 2012; HR 2741, Preventing Diabetes in Medicare Act of 2011 and Prediabetes generally; Medicaid coverage of obesity counseling and expanding provider type; Issues related to Medicare Part D and Medicaid rebates as contained in P.L. 112-25 Budget Control Act of 2011 (deficit reduction)
Preventing Diabetes in Medicare Act of 2011
Client: NOVO NORDISK INC. · Firm: NOVO NORDISK INC.
P.L. 111-148, Patient Protection and Affordable Care Act of 2009 (ACA) and P.L. 111-152, The Health Care & Education Affordability Reconciliation Act of 2010; CMS Proposed Coverage Decision Memorandum for Intensive Behavioral Therapy for Obesity; Medicare Diabetes Screening; HR 6548 Medicare Diabetes Prevention Act of 2012; S 3463 Medicare Diabetes Prevention Act of 2012; HR 2741, Preventing Diabetes in Medicare Act of 2011 and Prediabetes generally; Medicaid coverage of obesity counseling and expanding provider type; Issues related to Medicare Part D and Medicaid rebates as contained in P.L. 112-25 Budget Control Act of 2011 (deficit reduction) and HR 8 American Taxpayer Relief Act of 2012
Health Equity and Accountability Act of 2011
Client: NOVO NORDISK INC. · Firm: NOVO NORDISK INC.
Supporting increasing funding opportunities for better care and treatment of people with diabetes in P.L. 111-148, Patient Protection and Affordable Care Act of 2009 (ACA) and P.L. 111-152, The Health Care & Education Affordability Reconciliation Act of 2010: Issues related to diabetes generally, and specifically minority health, diabetes screening, National Diabetes Prevention Program, Special Diabetes Program reauthorization, National Prevention Strategy, Medicaid Quality Measures, Medicare Annual Wellness Visit, ACOs (related to Medicare Share Savings Program), Coverage of Preventive Services under ACA, HHS Strategic Plan, HHS Multiple Chronic Conditions Framework, National Quality Strategy, Prevention and Public Health Fund, Diabetes Prevention Issues in a Survey of Primary Care Physicians, Adequate Inclusion of Diabetes Care in the Essential Health Benefits Package, IOM Committee on Valuing Community-Based Non-Clinical Prevention Policies and Wellness Strategies, DOL Survey of Employer-Sponsored Health Insurance Coverage, CDC National Survey of Primary Care Policies for Managing Patients with Higher Blood Pressure, High Cholesterol, or Diabetes (NSPCP); H.R. 2954, the Health Equity and Accountability Act of 2011; HR 2960 National Diabetes Clinical Care Commission Act; S. 1559 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act FY2012 on National Diabetes Prevention Program; CMS Obesity Intervention; Healthy People 2020 Abstract; CMS CLIA Program & HIPAA Privacy Rule Patient Access to Test Reports; AHRQ regarding the USPSTF recommendation on screening and management of obesity in adults; PCORI Draft Research Agenda
Health Equity and Accountability Act of 2011
Client: NOVO NORDISK INC. · Firm: NOVO NORDISK INC.
Supporting increasing funding opportunities for better care and treatment of people with diabetes in P.L. 111-148, Patient Protection and Affordable Care Act of 2009 (ACA) and P.L. 111-152, The Health Care & Education Affordability Reconciliation Act of 2010: Issues related to diabetes generally, and specifically minority health, diabetes screening, National Diabetes Prevention Program, National Prevention Strategy, Medicaid Quality Measures, Medicare Annual Wellness Visit, ACOs (related to Medicare Share Savings Program), Coverage of Preventive Services under ACA, HHS Strategic Plan, HHS Multiple Chronic Conditions Framework, National Quality Strategy, Prevention and Public Health Fund, Diabetes Prevention Issues in a Survey of Primary Care Physicians, Adequate Inclusion of Diabetes Care In the Essential Health Benefits Package, IOM Committee on Valuing Community-based Non-Clinical Prevention Policies and Wellness Strategies, DOL Survey of Employer-Sponsored Health Insurance Coverage, CDC National Survey of Primary Care Policies for Managing Patients with Higher Blood Pressure, High Cholesterol, or Diabetes (NSPCP); H.R. 2954, the Health Equity and Accountability Act of 2011; HR 2960 National Diabetes Clinical Care Commission Act; S. 1559 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act FY2012 on National Diabetes Prevention Program; CMS Obesity Intervention; Healthy People 2020 Abstract; CMS CLIA Program & HIPAA Privacy Rule Patient Access to Test Reports; AHRQ regarding the USPSTF recommendation on screening and management of obesity in adults; PCORI Draft Research Agenda
National Diabetes Clinical Care Commission Act
Client: NOVO NORDISK INC. · Firm: NOVO NORDISK INC.
Supporting increasing funding opportunities for better care and treatment of people with diabetes in P.L. 111-148, Patient Protection and Affordable Care Act of 2009 (ACA) and P.L. 111-152, The Health Care & Education Affordability Reconciliation Act of 2010: Issues related to diabetes generally, and specifically minority health, diabetes screening, National Diabetes Prevention Program, National Prevention Strategy, Medicaid Quality Measures, Medicare Annual Wellness Visit, ACOs (related to Medicare Share Savings Program), Coverage of Preventive Services under ACA, HHS Strategic Plan, HHS Multiple Chronic Conditions Framework, National Quality Strategy, Prevention and Public Health Fund, Diabetes Prevention Issues in a Survey of Primary Care Physicians, Adequate Inclusion of Diabetes Care In the Essential Health Benefits Package, IOM Committee on Valuing Community-based Non-Clinical Prevention Policies and Wellness Strategies, DOL Survey of Employer-Sponsored Health Insurance Coverage, CDC National Survey of Primary Care Policies for Managing Patients with Higher Blood Pressure, High Cholesterol, or Diabetes (NSPCP); H.R. 2954, the Health Equity and Accountability Act of 2011; HR 2960 National Diabetes Clinical Care Commission Act; S. 1559 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act FY2012 on National Diabetes Prevention Program; CMS Obesity Intervention; Healthy People 2020 Abstract; CMS CLIA Program & HIPAA Privacy Rule Patient Access to Test Reports; AHRQ regarding the USPSTF recommendation on screening and management of obesity in adults; PCORI Draft Research Agenda
National Diabetes Clinical Care Commission Act
Client: NOVO NORDISK INC. · Firm: NOVO NORDISK INC.
Supporting increasing funding opportunities for better care and treatment of people with diabetes in P.L. 111-148, Patient Protection and Affordable Care Act of 2009 (ACA) and P.L. 111-152, The Health Care & Education Affordability Reconciliation Act of 2010: Issues related to diabetes generally, and specifically minority health, diabetes screening, National Diabetes Prevention Program, Special Diabetes Program reauthorization, National Prevention Strategy, Medicaid Quality Measures, Medicare Annual Wellness Visit, ACOs (related to Medicare Share Savings Program), Coverage of Preventive Services under ACA, HHS Strategic Plan, HHS Multiple Chronic Conditions Framework, National Quality Strategy, Prevention and Public Health Fund, Diabetes Prevention Issues in a Survey of Primary Care Physicians, Adequate Inclusion of Diabetes Care in the Essential Health Benefits Package, IOM Committee on Valuing Community-Based Non-Clinical Prevention Policies and Wellness Strategies, DOL Survey of Employer-Sponsored Health Insurance Coverage, CDC National Survey of Primary Care Policies for Managing Patients with Higher Blood Pressure, High Cholesterol, or Diabetes (NSPCP); H.R. 2954, the Health Equity and Accountability Act of 2011; HR 2960 National Diabetes Clinical Care Commission Act; S. 1559 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act FY2012 on National Diabetes Prevention Program; CMS Obesity Intervention; Healthy People 2020 Abstract; CMS CLIA Program & HIPAA Privacy Rule Patient Access to Test Reports; AHRQ regarding the USPSTF recommendation on screening and management of obesity in adults; PCORI Draft Research Agenda
Safeguarding America's Pharmaceuticals Act of 2011
Client: NOVO NORDISK INC. · Firm: NOVO NORDISK INC.
P.L. 111-148, Patient Protection and Affordable Care Act of 2009 (ACA) and P.L. 111-152, The Health Care & Education Affordability Reconciliation Act of 2010: Issues regarding comparative effectiveness, implementation of Physician Payment Sunshine provisions and Prescription Drug Sample reporting provisions; S.3187 FDA Safety and Innovation Act (PDUFA V); H.R. 4274 Best Pharmaceuticals for Children Act/Pediatric Research Exclusivity Act; H.R. 3026 Safeguarding America's Pharmaceuticals Act of 2011; Pharmaceutical Traceability Enhancement Code (Rx TEC) Act; H.R. 5973 FY2013 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act (FDA funding); 340B
Safeguarding America's Pharmaceuticals Act of 2011
Client: NOVO NORDISK INC. · Firm: NOVO NORDISK INC.
P.L. 111-148, Patient Protection and Affordable Care Act of 2009 (ACA) and P.L. 111-152, The Health Care & Education Affordability Reconciliation Act of 2010: Issues regarding comparative effectiveness, implementation of Physician Payment Sunshine provisions and Prescription Drug Sample reporting provisions; S.3187 FDA Safety and Innovation Act; H.R. 4274 Best Pharmaceuticals for Children Act/Pediatric Research Exclusivity Act; H.R. 3026 Safeguarding America's Pharmaceuticals Act of 2011; Pharmaceutical Traceability Enhancement Code (Rx TEC) Act; H.R. 5973 FY2013 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act (FDA funding); 340B
Safeguarding America's Pharmaceuticals Act of 2011
Client: NOVO NORDISK INC. · Firm: NOVO NORDISK INC.
P.L. 111-148, Patient Protection and Affordable Care Act of 2009 (ACA) and P.L. 111-152, The Health Care & Education Affordability Reconciliation Act of 2010: Issues regarding comparative effectiveness, implementation of Physician Payment Sunshine provisions and Prescription Drug Sample reporting provisions; S.3187 FDA Safety and Innovation Act; H.R. 4274 Best Pharmaceuticals for Children Act/Pediatric Research Exclusivity Act; H.R. 3026 Safeguarding America's Pharmaceuticals Act of 2011; Pharmaceutical Traceability Enhancement Code (Rx TEC) Act and draft legislation on downstream supply chain safety/serialization; H.R. 5973 FY2013 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act (FDA funding); 340B; HR 1513 / S 810 Great Apes Protection Act
Temporary Payroll Tax Cut Continuation Act of 2011
Client: NOVO NORDISK INC. · Firm: NOVO NORDISK INC.
P.L. 111-148, Patient Protection and Affordable Care Act of 2009 (ACA) and P.L. 111-152, The Health Care & Education Affordability Reconciliation Act of 2010; CMS Proposed Coverage Decision Memorandum for Intensive Behavioral Therapy for Obesity; Medicare Diabetes Screening; HR 2741, Preventing Diabetes in Medicare Act of 2011 and Prediabetes generally; Issues related to Medicaid rebates and similar revenue provisions as contained in P.L. 112-25, Budget Control Act of 2011 (deficit reduction); HR 3743 Middle Class Tax Relief and Job Creation Act of 2011, HR 3630 Middle Class Tax Relief and Job Creation Act of 2011, and HR 3765 (PL 112-78) Temporary Payroll Tax Cut Continuation of 2011-Issues related to Medicaid rebates and similar revenue provisions; Medicaid coverage of obesity counseling and expanding provider type.
Temporary Payroll Tax Cut Continuation Act of 2011
Client: NOVO NORDISK INC. · Firm: NOVO NORDISK INC.
P.L. 111-148, Patient Protection and Affordable Care Act of 2009 (ACA) and P.L. 111-152, The Health Care & Education Affordability Reconciliation Act of 2010; CMS Proposed Coverage Decision Memorandum for Intensive Behavioral Therapy for Obesity; Medicare Diabetes Screening; HR 2741, Preventing Diabetes in Medicare Act of 2011 and Prediabetes generally; Issues related to Medicaid rebates and similar revenue provisions as contained in P.L. 112-25, Budget Control Act of 2011 (deficit reduction); HR 3743 Middle Class Tax Relief and Job Creation Act of 2011, HR 3630 Middle Class Tax Relief and Job Creation Act of 2011, and HR 3765 (PL 112-78) Temporary Payroll Tax Cut Continuation of 2011-Issues related to Medicaid rebates and similar revenue provisions; Medicaid coverage of obesity counseling and expanding provider type.
S. 1002 SAFE DOSES Act and HR 4223 Safe Doses Act (Modernizing criminal laws concerning theft of medical products)
S. 1002 SAFE DOSES Act and HR 4223 Safe Doses Act (Modernizing criminal laws concerning theft of medical products)
S. 1002 SAFE DOSES Act and HR 4223 Safe Doses Act (Modernizing criminal laws concerning theft of medical products)
BPCA and PREA Reauthorization Act of 2012
Client: NOVO NORDISK INC. · Firm: NOVO NORDISK INC.
P.L. 111-148, Patient Protection and Affordable Care Act of 2009 (ACA) and P.L. 111-152, The Health Care & Education Affordability Reconciliation Act of 2010: Issues regarding comparative effectiveness, implementation of Physician Payment Sunshine provisions and Prescription Drug Sample reporting provisions; S.3187 FDA Safety and Innovation Act; H.R. 4274 Best Pharmaceuticals for Children Act/Pediatric Research Exclusivity Act; H.R. 3026 Safeguarding America's Pharmaceuticals Act of 2011; Pharmaceutical Traceability Enhancement Code (Rx TEC) Act and draft legislation on downstream supply chain safety/serialization; H.R. 5973 FY2013 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act (FDA funding); 340B; HR 1513 / S 810 Great Apes Protection Act
BPCA and PREA Reauthorization Act of 2012
Client: NOVO NORDISK INC. · Firm: NOVO NORDISK INC.
P.L. 111-148, Patient Protection and Affordable Care Act of 2009 (ACA) and P.L. 111-152, The Health Care & Education Affordability Reconciliation Act of 2010: Issues regarding comparative effectiveness, implementation of Physician Payment Sunshine provisions and Prescription Drug Sample reporting provisions; S.3187 FDA Safety and Innovation Act; H.R. 4274 Best Pharmaceuticals for Children Act/Pediatric Research Exclusivity Act; H.R. 3026 Safeguarding America's Pharmaceuticals Act of 2011; Pharmaceutical Traceability Enhancement Code (Rx TEC) Act; H.R. 5973 FY2013 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act (FDA funding); 340B
BPCA and PREA Reauthorization Act of 2012
Client: NOVO NORDISK INC. · Firm: NOVO NORDISK INC.
P.L. 111-148, Patient Protection and Affordable Care Act of 2009 (ACA) and P.L. 111-152, The Health Care & Education Affordability Reconciliation Act of 2010: Issues regarding comparative effectiveness, implementation of Physician Payment Sunshine provisions and Prescription Drug Sample reporting provisions; S.3187 FDA Safety and Innovation Act (PDUFA V); H.R. 4274 Best Pharmaceuticals for Children Act/Pediatric Research Exclusivity Act; H.R. 3026 Safeguarding America's Pharmaceuticals Act of 2011; Pharmaceutical Traceability Enhancement Code (Rx TEC) Act; H.R. 5973 FY2013 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act (FDA funding); 340B
H.R. 436 Protect Medical Innovation Act of 2011
H.R. 436 Protect Medical Innovation Act of 2011; HR 8 American Taxpayer Relief Act of 2012 (R&D credit)
H.R. 436 Protect Medical Innovation Act of 2011
H.R. 436 Protect Medical Innovation Act of 2011
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2013
Client: NOVO NORDISK INC. · Firm: NOVO NORDISK INC.
P.L. 111-148, Patient Protection and Affordable Care Act of 2009 (ACA) and P.L. 111-152, The Health Care & Education Affordability Reconciliation Act of 2010: Issues regarding comparative effectiveness, implementation of Physician Payment Sunshine provisions and Prescription Drug Sample reporting provisions; S.3187 FDA Safety and Innovation Act; H.R. 4274 Best Pharmaceuticals for Children Act/Pediatric Research Exclusivity Act; H.R. 3026 Safeguarding America's Pharmaceuticals Act of 2011; Pharmaceutical Traceability Enhancement Code (Rx TEC) Act; H.R. 5973 FY2013 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act (FDA funding); 340B
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2013
Client: NOVO NORDISK INC. · Firm: NOVO NORDISK INC.
P.L. 111-148, Patient Protection and Affordable Care Act of 2009 (ACA) and P.L. 111-152, The Health Care & Education Affordability Reconciliation Act of 2010: Issues regarding comparative effectiveness, implementation of Physician Payment Sunshine provisions and Prescription Drug Sample reporting provisions; S.3187 FDA Safety and Innovation Act; H.R. 4274 Best Pharmaceuticals for Children Act/Pediatric Research Exclusivity Act; H.R. 3026 Safeguarding America's Pharmaceuticals Act of 2011; Pharmaceutical Traceability Enhancement Code (Rx TEC) Act and draft legislation on downstream supply chain safety/serialization; H.R. 5973 FY2013 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act (FDA funding); 340B; HR 1513 / S 810 Great Apes Protection Act
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2013
Client: NOVO NORDISK INC. · Firm: NOVO NORDISK INC.
P.L. 111-148, Patient Protection and Affordable Care Act of 2009 (ACA) and P.L. 111-152, The Health Care & Education Affordability Reconciliation Act of 2010: Issues regarding comparative effectiveness, implementation of Physician Payment Sunshine provisions and Prescription Drug Sample reporting provisions; S.3187 FDA Safety and Innovation Act (PDUFA V); H.R. 4274 Best Pharmaceuticals for Children Act/Pediatric Research Exclusivity Act; H.R. 3026 Safeguarding America's Pharmaceuticals Act of 2011; Pharmaceutical Traceability Enhancement Code (Rx TEC) Act; H.R. 5973 FY2013 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act (FDA funding); 340B
To amend the Congressional Budget Act of 1974 respecting the scoring of preventive health savings.
Client: NOVO NORDISK INC. · Firm: NOVO NORDISK INC.
S. 3295 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act FY2013 (National Diabetes Prevention Program); HR 6482 The Preventative Health Savings Act of 2012 (modernizing cost estimates with respect to CBO scoring of preventive health legislation); and National Diabetes Prevention Program
To amend the Congressional Budget Act of 1974 respecting the scoring of preventive health savings.
Client: NOVO NORDISK INC. · Firm: NOVO NORDISK INC.
S. 3295 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act FY2013 (National Diabetes Prevention Program); HR 6482 The Preventative Health Savings Act of 2012 (modernizing cost estimates with respect to CBO scoring of preventive health legislation); and National Diabetes Prevention Program
P.L. 111-148, Patient Protection and Affordable Care Act of 2009 (ACA) and P.L. 111-152, The Health Care & Education Affordability Reconciliation Act of 2010; CMS Proposed Coverage Decision Memorandum for Intensive Behavioral Therapy for Obesity; Medicare Diabetes Screening; HR 6548 Medicare Diabetes Prevention Act of 2012; S 3463 Medicare Diabetes Prevention Act of 2012; HR 2741, Preventing Diabetes in Medicare Act of 2011 and Prediabetes generally; Medicaid coverage of obesity counseling and expanding provider type; Issues related to Medicare Part D and Medicaid rebates as contained in P.L. 112-25 Budget Control Act of 2011 (deficit reduction)
P.L. 111-148, Patient Protection and Affordable Care Act of 2009 (ACA) and P.L. 111-152, The Health Care & Education Affordability Reconciliation Act of 2010; CMS Proposed Coverage Decision Memorandum for Intensive Behavioral Therapy for Obesity; Medicare Diabetes Screening; HR 6548 Medicare Diabetes Prevention Act of 2012; S 3463 Medicare Diabetes Prevention Act of 2012; HR 2741, Preventing Diabetes in Medicare Act of 2011 and Prediabetes generally; Medicaid coverage of obesity counseling and expanding provider type; Issues related to Medicare Part D and Medicaid rebates as contained in P.L. 112-25 Budget Control Act of 2011 (deficit reduction) and HR 8 American Taxpayer Relief Act of 2012
To correct and improve certain provisions of the Leahy-Smith America Invents Act and title 35, United States Code.
Client: NOVO NORDISK INC. · Firm: NOVO NORDISK INC.
HR 6621 Technical corrections to the America Invents Act; S. 3486, the Patent Law Treaties Implementation Act of 2012
P.L. 111-148, Patient Protection and Affordable Care Act of 2009 (ACA) and P.L. 111-152, The Health Care & Education Affordability Reconciliation Act of 2010; CMS Proposed Coverage Decision Memorandum for Intensive Behavioral Therapy for Obesity; Medicare Diabetes Screening; HR 6548 Medicare Diabetes Prevention Act of 2012; S 3463 Medicare Diabetes Prevention Act of 2012; HR 2741, Preventing Diabetes in Medicare Act of 2011 and Prediabetes generally; Medicaid coverage of obesity counseling and expanding provider type; Issues related to Medicare Part D and Medicaid rebates as contained in P.L. 112-25 Budget Control Act of 2011 (deficit reduction) and HR 8 American Taxpayer Relief Act of 2012
H.R. 436 Protect Medical Innovation Act of 2011; HR 8 American Taxpayer Relief Act of 2012 (R&D credit)
S. 1002 SAFE DOSES Act and HR 4223 Safe Doses Act (Modernizing criminal laws concerning theft of medical products)
S. 1002 SAFE DOSES Act and HR 4223 Safe Doses Act (Modernizing criminal laws concerning theft of medical products)
S. 1002 SAFE DOSES Act and HR 4223 Safe Doses Act (Modernizing criminal laws concerning theft of medical products)
FY12 Budget Resolution: diabetes-related issues and issues related to modernizing cost estimates with respect to preventive health legislation; HR 2608 (PL 112-36) Continuing Appropriations Act, 2012; HJ RES 94 (PL 112-67); CR through 12/17/11; HJ RES 95 (PL 112-68) CR through 12/23/11; P.L. 112-74 Consolidated Appropriations Act of 2012 on National Diabetes Prevention Program
Preventing Diabetes in Medicare Act of 2011
Client: NOVO NORDISK INC. · Firm: NOVO NORDISK INC.
P.L. 111-148, Patient Protection and Affordable Care Act of 2009 (ACA) and P.L. 111-152, The Health Care & Education Affordability Reconciliation Act of 2010; CMS Proposed Coverage Decision Memorandum for Intensive Behavioral Therapy for Obesity; Medicare Diabetes Screening; HR 2741, Preventing Diabetes in Medicare Act of 2011 and Prediabetes generally; Issues related to Medicaid rebates and similar revenue provisions as contained in P.L. 112-25, Budget Control Act of 2011 (deficit reduction); HR 3743 Middle Class Tax Relief and Job Creation Act of 2011, HR 3630 Middle Class Tax Relief and Job Creation Act of 2011, and HR 3765 (PL 112-78) Temporary Payroll Tax Cut Continuation of 2011-Issues related to Medicaid rebates and similar revenue provisions
Health Equity and Accountability Act of 2011
Client: NOVO NORDISK INC. · Firm: NOVO NORDISK INC.
Supporting increasing funding opportunities for better care and treatment of people with diabetes in P.L. 111-148, Patient Protection and Affordable Care Act of 2009 (ACA) and P.L. 111-152, The Health Care & Education Affordability Reconciliation Act of 2010: Issues related to diabetes generally, and specifically minority health, diabetes screening, National Diabetes Prevention Program, National Prevention Strategy, Medicaid Quality Measures, Medicare Annual Wellness Visit, ACOs (related to Medicare Share Savings Program), Coverage of Preventive Services under ACA, HHS Strategic Plan, HHS Multiple Chronic Conditions Framework, National Quality Strategy, Prevention and Public Health Fund, Diabetes Prevention Issues in a Survey of Primary Care Physicians, Adequate Inclusion of Diabetes Care In the Essential Health Benefits Package, IOM Committee on Valuing Community-based Non-Clinical Prevention Policies and Wellness Strategies, DOL Survey of Employer-Sponsored Health Insurance Coverage, CDC National Survey of Primary Care Policies for Managing Patients with Higher Blood Pressure, High Cholesterol, or Diabetes (NSPCP); H.R. 2954, the Health Equity and Accountability Act of 2011; HR 2960 National Diabetes Clinical Care Commission Act; S. 1559 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act FY2012
Health Equity and Accountability Act of 2011
Client: NOVO NORDISK INC. · Firm: NOVO NORDISK INC.
Supporting increasing funding opportunities for better care and treatment of people with diabetes in P.L. 111-148, Patient Protection and Affordable Care Act of 2009 (ACA) and P.L. 111-152, The Health Care & Education Affordability Reconciliation Act of 2010: Issues related to diabetes generally, and specifically minority health, diabetes screening, National Diabetes Prevention Program, National Prevention Strategy, Medicaid Quality Measures, Medicare Annual Wellness Visit, ACOs (related to Medicare Share Savings Program), Coverage of Preventive Services under ACA, HHS Strategic Plan, HHS Multiple Chronic Conditions Framework, National Quality Strategy, Prevention and Public Health Fund, Diabetes Prevention Issues in a Survey of Primary Care Physicians, Adequate Inclusion of Diabetes Care In the Essential Health Benefits Package, IOM Committee on Valuing Community-based Non-Clinical Prevention Policies and Wellness Strategies, DOL Survey of Employer-Sponsored Health Insurance Coverage, CDC National Survey of Primary Care Policies for Managing Patients with Higher Blood Pressure, High Cholesterol, or Diabetes (NSPCP); H.R. 2954, the Health Equity and Accountability Act of 2011; HR 2960 National Diabetes Clinical Care Commission Act; S. 1559 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act FY2012 on National Diabetes Prevention Program; CMS Obesity Intervention; Healthy People 2020 Abstract; CMS CLIA Program & HIPAA Privacy Rule Patient Access to Test Reports; AHRQ regarding the USPSTF recommendation on screening and management of obesity in adults
National Diabetes Clinical Care Commission Act
Client: NOVO NORDISK INC. · Firm: NOVO NORDISK INC.
Supporting increasing funding opportunities for better care and treatment of people with diabetes in P.L. 111-148, Patient Protection and Affordable Care Act of 2009 (ACA) and P.L. 111-152, The Health Care & Education Affordability Reconciliation Act of 2010: Issues related to diabetes generally, and specifically minority health, diabetes screening, National Diabetes Prevention Program, National Prevention Strategy, Medicaid Quality Measures, Medicare Annual Wellness Visit, ACOs (related to Medicare Share Savings Program), Coverage of Preventive Services under ACA, HHS Strategic Plan, HHS Multiple Chronic Conditions Framework, National Quality Strategy, Prevention and Public Health Fund, Diabetes Prevention Issues in a Survey of Primary Care Physicians, Adequate Inclusion of Diabetes Care In the Essential Health Benefits Package, IOM Committee on Valuing Community-based Non-Clinical Prevention Policies and Wellness Strategies, DOL Survey of Employer-Sponsored Health Insurance Coverage, CDC National Survey of Primary Care Policies for Managing Patients with Higher Blood Pressure, High Cholesterol, or Diabetes (NSPCP); H.R. 2954, the Health Equity and Accountability Act of 2011; HR 2960 National Diabetes Clinical Care Commission Act; S. 1559 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act FY2012
National Diabetes Clinical Care Commission Act
Client: NOVO NORDISK INC. · Firm: NOVO NORDISK INC.
Supporting increasing funding opportunities for better care and treatment of people with diabetes in P.L. 111-148, Patient Protection and Affordable Care Act of 2009 (ACA) and P.L. 111-152, The Health Care & Education Affordability Reconciliation Act of 2010: Issues related to diabetes generally, and specifically minority health, diabetes screening, National Diabetes Prevention Program, National Prevention Strategy, Medicaid Quality Measures, Medicare Annual Wellness Visit, ACOs (related to Medicare Share Savings Program), Coverage of Preventive Services under ACA, HHS Strategic Plan, HHS Multiple Chronic Conditions Framework, National Quality Strategy, Prevention and Public Health Fund, Diabetes Prevention Issues in a Survey of Primary Care Physicians, Adequate Inclusion of Diabetes Care In the Essential Health Benefits Package, IOM Committee on Valuing Community-based Non-Clinical Prevention Policies and Wellness Strategies, DOL Survey of Employer-Sponsored Health Insurance Coverage, CDC National Survey of Primary Care Policies for Managing Patients with Higher Blood Pressure, High Cholesterol, or Diabetes (NSPCP); H.R. 2954, the Health Equity and Accountability Act of 2011; HR 2960 National Diabetes Clinical Care Commission Act; S. 1559 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act FY2012 on National Diabetes Prevention Program; CMS Obesity Intervention; Healthy People 2020 Abstract; CMS CLIA Program & HIPAA Privacy Rule Patient Access to Test Reports; AHRQ regarding the USPSTF recommendation on screening and management of obesity in adults
Temporary Payroll Tax Cut Continuation Act of 2011
Client: NOVO NORDISK INC. · Firm: NOVO NORDISK INC.
P.L. 111-148, Patient Protection and Affordable Care Act of 2009 (ACA) and P.L. 111-152, The Health Care & Education Affordability Reconciliation Act of 2010; CMS Proposed Coverage Decision Memorandum for Intensive Behavioral Therapy for Obesity; Medicare Diabetes Screening; HR 2741, Preventing Diabetes in Medicare Act of 2011 and Prediabetes generally; Issues related to Medicaid rebates and similar revenue provisions as contained in P.L. 112-25, Budget Control Act of 2011 (deficit reduction); HR 3743 Middle Class Tax Relief and Job Creation Act of 2011, HR 3630 Middle Class Tax Relief and Job Creation Act of 2011, and HR 3765 (PL 112-78) Temporary Payroll Tax Cut Continuation of 2011-Issues related to Medicaid rebates and similar revenue provisions
Temporary Payroll Tax Cut Continuation Act of 2011
Client: NOVO NORDISK INC. · Firm: NOVO NORDISK INC.
P.L. 111-148, Patient Protection and Affordable Care Act of 2009 (ACA) and P.L. 111-152, The Health Care & Education Affordability Reconciliation Act of 2010; CMS Proposed Coverage Decision Memorandum for Intensive Behavioral Therapy for Obesity; Medicare Diabetes Screening; HR 2741, Preventing Diabetes in Medicare Act of 2011 and Prediabetes generally; Issues related to Medicaid rebates and similar revenue provisions as contained in P.L. 112-25, Budget Control Act of 2011 (deficit reduction); HR 3743 Middle Class Tax Relief and Job Creation Act of 2011, HR 3630 Middle Class Tax Relief and Job Creation Act of 2011, and HR 3765 (PL 112-78) Temporary Payroll Tax Cut Continuation of 2011-Issues related to Medicaid rebates and similar revenue provisions
H.R. 436 Protect Medical Innovation Act of 2011
H.R. 436 Protect Medical Innovation Act of 2011
H.R. 436 Protect Medical Innovation Act of 2011
S. 1002 SAFE DOSES Act (Modernizing criminal laws concerning theft of medical products)
S. 1002 SAFE DOSES Act (Modernizing criminal laws concerning theft of medical products)
S. 1002 SAFE DOSES Act (Modernizing criminal laws concerning theft of medical products)
Setting forth the congressional budget for the United States Government for fiscal year 2010 and including the appropriate budgetary levels for fiscal years 2009 and 2011 through 2014.
Client: NOVO NORDISK INC. · Firm: NOVO NORDISK INC.
H. Con. Res. 85, S. Con. Res. 13, and H.R. 4851, Continuing Extension Act of 2010; P.L. 111-148, Patient Protection and Affordable Care Act of 2009; P.L. 111-152, The Health Care & Education Affordability Reconciliation Act of 2010; issues regarding comparative effectiveness
H.R. 1260 and S. 515, Patent Reform Act of 2009, entire bill; H.R. 1408, Sunshine in Litigation Act
H.R. 1260 and S. 515, Patent Reform Act of 2009, entire bill; H.R. 1408, Sunshine in Litigation Act
H.R. 1260 and S. 515, Patent Reform Act of 2009, entire bill; H.R. 1408, Sunshine in Litigation Act
H.R. 1260 and S. 515, Patent Reform Act of 2009, entire bill; H.R. 1408, Sunshine in Litigation Act
Diabetes in Minority Populations Evaluation Act of 2010
Client: NOVO NORDISK INC. · Firm: NOVO NORDISK INC.
H.R. 1995, S. 844, Eliminating Disparities in Diabetes Prevention Access and Care Act and the Diabetes in Minority Populations Evaluations Act; H.R. 3090, Health Equity and Accountability Act; P.L. 111-148, Patient Protection and Affordable Care Act of 2009; P.L. 111-152, The Health Care & Education Affordability Reconciliation Act of 2010, issues related to minority health
Health Equity and Accountability Act of 2009
Client: NOVO NORDISK INC. · Firm: NOVO NORDISK INC.
H.R. 1995, S. 844, Eliminating Disparities in Diabetes Prevention Access and Care Act and the Diabetes in Minority Populations Evaluations Act; H.R. 3090, Health Equity and Accountability Act; P.L. 111-148, Patient Protection and Affordable Care Act of 2009; P.L. 111-152, The Health Care & Education Affordability Reconciliation Act of 2010, issues related to minority health
To amend the Congressional Budget Act of 1974 respecting the scoring of preventive health savings.
Client: NOVO NORDISK INC. · Firm: NOVO NORDISK INC.
H.R. 3148, the Preventive Health Savings Act
To amend the Congressional Budget Act of 1974 respecting the scoring of preventive health savings.
Client: NOVO NORDISK INC. · Firm: NOVO NORDISK INC.
H.R. 3148, the Preventive Health Savings Act; H.R. 3663 and S. 3058, To amend the Public Health Service Act to reauthorize the special diabetes programs for Type I diabetes and Indians under that Act; S. 3686 Labor, Health and Human Services, and Education Appropriations Act, 2011, diabetes-related provisions
To amend title XVIII of the Social Security Act to delay the date on which the accreditation requirement under the Medicare Program applies to suppliers of durable medical equipment that are pharmacies.
Client: NOVO NORDISK INC. · Firm: NOVO NORDISK INC.
H.R. 3148, the Preventive Health Savings Act; H.R. 3663 and S. 3058, To amend the Public Health Service Act to reauthorize the special diabetes programs for Type I diabetes and Indians under that Act; S. 3686 Labor, Health and Human Services, and Education Appropriations Act, 2011, diabetes-related provisions
H.R.1919 Safeguarding America's Pharmaceuticals Act of 2013 and S.959 Pharmaceutical Compounding Quality and Accountability Act (for track and trace supply chain provisions); issues regarding biosimilars; 340B
Issues related to insulin pen safety and access in the VA
Issues related to patent litigation and patent assertion entities (PAEs) aka patent trolls
Issues related to Medicare Part D, FDA and patents in S. Con. Res. 8 FY14 Senate Budget Resolution; H. Con. Res. 25 House Budget Resolution; H.R. 2663 The Preventative Health Savings Act of 2013 (Modernizing CBO scoring estimates with respect to preventive health legislation); National Diabetes Prevention Program in H.R. 933 -- FY13 Consolidated and Further Continuing Appropriations Act and S. 1284 FY14 Depts. of Labor, Health and Human Services, and Education Appropriations Act
National Diabetes Prevention Program; Better care and treatment of people with diabetes under P.L. 111-148 Patient Protection and Affordable Care Act of 2009 (ACA) and P.L. 111-152 The Health Care & Education Affordability Reconciliation Act of 2010: Issues related to diabetes generally, and specifically diabetes screening, medical education and death certificate reporting (Catalyst for Better Diabetes), Prevention and Public Health Fund, AHRQ and USPSTF diabetes screening standards;diabetes issues in Healthy People 2020 and the Office of Disease Prevention and Health Promotion (ODPHP); H.R. 1074 and S. 539 National Diabetes Clinical Care Commission Act of 2013; human growth / rare disorders awareness; H.R. 8 American Taxpayer Relief Act (Special Diabetes Program reauthorization); gestational diabetes; diabetes disparities; H.R. 351 and S. 351 Protecting Seniors' Access to Medicare Act of 2013 (IPAB repeal)
EU/US Transatlantic Trade and Investment Partnership (TTIP) (intellectual property); Trans-Pacific Partnership (TPP) (intellectual property)
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE, Veterans Affairs, Dept of (VA)
NOVO NORDISK INC. via NOVO NORDISK INC.
2013 · first_quarter · Q1
HR 8 American Taxpayer Relief Act (R&D tax credit) of 2012 (R&D credit)
Issues related to Medicare Part D, FDA and patents in S. Con. Res. 8 FY14 Senate Budget Resolution; H Con Res. 25 House Budget Resolution; Modernizing cost estimates with respect to preventive health legislation (CBO scoring); National Diabetes Prevention Program; HR 933 -- Consolidated and Further Continuing Appropriations Act, 2013
Issues related to Medicare Part D and Medicaid rebates as contained in P.L. 112-25 Budget Control Act of 2011 and H.R. 8 American Taxpayer Relief Actof 2012; H.R. 962 and S. 452 Medicare Diabetes Prevention Act of 2013; H.R. 1257 Preventing Diabetes in Medicare Act of 2013 and prediabetes generally; H.R. 1274 Access to Quality Diabetes Education Act of 2013 (Diabetes Self-Management Training in Medicare); Medicare diabetes screening generally
National Diabetes Prevention Program; Better care and treatment of people with diabetes under P.L. 111-148 Patient Protection and Affordable Care Act of 2009 (ACA) and P.L. 111-152 The Health Care & Education Affordability Reconciliation Act of 2010: Issues related to diabetes generally, and specifically diabetes screening, medical education and death certificate reporting (Catalyst for Better Diabetes), Prevention and Public Health Fund, AHRQ and USPSTF diabetes screening standards;diabetes issues in Healthy People 2020 and the Office of Disease Prevention and Health Promotion (ODPHP); H.R. 1074 and S 539 National Diabetes Clinical Care Commission Act of 2013; human growth / rare disorders awareness; H.R. 8 American Taxpayer Relief Act (Special Diabetes Program reauthorization); gestational diabetes; diabetes disparities; H.R. 351 and S. 351 Protecting Seniors' Access to Medicare Act of 2013 (IPAB repeal)
Issues regarding Pharmaceutical Traceability Enhancement Code (Rx TEC) Act and discussion draft on serialization (track and trace); S.622 -- Animal Drug and Animal Generic Drug User Fee Reauthorization Act of 2013 for amendments that would impact human drug user fees; issues regarding biosimilars; 340B
EU/US Transatlantic Trade and Investment Partnership (TTIP) (intellectual property); Trans-Pacific Partnership (TPP); intellectual property
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE
NOVO NORDISK INC. via NOVO NORDISK INC.
2012 · fourth_quarter · Q4
P.L. 111-148, Patient Protection and Affordable Care Act of 2009 (ACA) and P.L. 111-152, The Health Care & Education Affordability Reconciliation Act of 2010: Issues regarding comparative effectiveness, implementation of Physician Payment Sunshine provisions and Prescription Drug Sample reporting provisions; S.3187 FDA Safety and Innovation Act; H.R. 4274 Best Pharmaceuticals for Children Act/Pediatric Research Exclusivity Act; H.R. 3026 Safeguarding America's Pharmaceuticals Act of 2011; Pharmaceutical Traceability Enhancement Code (Rx TEC) Act and draft legislation on downstream supply chain safety/serialization; H.R. 5973 FY2013 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act (FDA funding); 340B; HR 1513 / S 810 Great Apes Protection Act
H.R. 436 Protect Medical Innovation Act of 2011; HR 8 American Taxpayer Relief Act of 2012 (R&D credit)
P.L. 111-148, Patient Protection and Affordable Care Act of 2009 (ACA) and P.L. 111-152, The Health Care & Education Affordability Reconciliation Act of 2010: biosimilar provisions
P.L. 112-186, SAFE DOSES Act (Modernizing criminal laws concerning theft of medical products)
HR 6621 Technical corrections to the America Invents Act; S. 3486, the Patent Law Treaties Implementation Act of 2012
S. 3295 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act FY2013 (National Diabetes Prevention Program); HR 6482 The Preventative Health Savings Act of 2012 (modernizing cost estimates with respect to CBO scoring of preventive health legislation); and National Diabetes Prevention Program
P.L. 111-148, Patient Protection and Affordable Care Act of 2009 (ACA) and P.L. 111-152, The Health Care & Education Affordability Reconciliation Act of 2010; CMS Proposed Coverage Decision Memorandum for Intensive Behavioral Therapy for Obesity; Medicare Diabetes Screening; HR 6548 Medicare Diabetes Prevention Act of 2012; S 3463 Medicare Diabetes Prevention Act of 2012; HR 2741, Preventing Diabetes in Medicare Act of 2011 and Prediabetes generally; Medicaid coverage of obesity counseling and expanding provider type; Issues related to Medicare Part D and Medicaid rebates as contained in P.L. 112-25 Budget Control Act of 2011 (deficit reduction) and HR 8 American Taxpayer Relief Act of 2012
Trans-Pacific Partnership (TPP): biosimilar provisions
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), Natl Institutes of Health (NIH), SENATE
NOVO NORDISK INC. via NOVO NORDISK INC.
2012 · third_quarter · Q3
P.L. 111-148, Patient Protection and Affordable Care Act of 2009 (ACA) and P.L. 111-152, The Health Care & Education Affordability Reconciliation Act of 2010: Issues regarding comparative effectiveness, implementation of Physician Payment Sunshine provisions and Prescription Drug Sample reporting provisions; S.3187 FDA Safety and Innovation Act; H.R. 4274 Best Pharmaceuticals for Children Act/Pediatric Research Exclusivity Act; H.R. 3026 Safeguarding America's Pharmaceuticals Act of 2011; Pharmaceutical Traceability Enhancement Code (Rx TEC) Act; H.R. 5973 FY2013 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act (FDA funding); 340B
H.R. 436 Protect Medical Innovation Act of 2011
Supporting increasing funding opportunities for better care and treatment of people with diabetes in P.L. 111-148, Patient Protection and Affordable Care Act of 2009 (ACA) and P.L. 111-152, The Health Care & Education Affordability Reconciliation Act of 2010: Issues related to diabetes generally, and specifically minority health, diabetes screening, National Diabetes Prevention Program, Special Diabetes Program reauthorization, National Prevention Strategy, Medicaid Quality Measures, Medicare Annual Wellness Visit, ACOs (related to Medicare Share Savings Program), Coverage of Preventive Services under ACA, HHS Strategic Plan, HHS Multiple Chronic Conditions Framework, National Quality Strategy, Prevention and Public Health Fund, Diabetes Prevention Issues in a Survey of Primary Care Physicians, Adequate Inclusion of Diabetes Care in the Essential Health Benefits Package, IOM Committee on Valuing Community-Based Non-Clinical Prevention Policies and Wellness Strategies, DOL Survey of Employer-Sponsored Health Insurance Coverage, CDC National Survey of Primary Care Policies for Managing Patients with Higher Blood Pressure, High Cholesterol, or Diabetes (NSPCP); H.R. 2954, the Health Equity and Accountability Act of 2011; HR 2960 National Diabetes Clinical Care Commission Act; S. 1559 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act FY2012 on National Diabetes Prevention Program; CMS Obesity Intervention; Healthy People 2020 Abstract; CMS CLIA Program & HIPAA Privacy Rule Patient Access to Test Reports; AHRQ regarding the USPSTF recommendation on screening and management of obesity in adults; PCORI Draft Research Agenda
S. 3295 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act FY2013 (National Diabetes Prevention Program); HR 6482 The Preventative Health Savings Act of 2012 (modernizing cost estimates with respect to CBO scoring of preventive health legislation); and National Diabetes Prevention Program
P.L. 111-148, Patient Protection and Affordable Care Act of 2009 (ACA) and P.L. 111-152, The Health Care & Education Affordability Reconciliation Act of 2010; CMS Proposed Coverage Decision Memorandum for Intensive Behavioral Therapy for Obesity; Medicare Diabetes Screening; HR 6548 Medicare Diabetes Prevention Act of 2012; S 3463 Medicare Diabetes Prevention Act of 2012; HR 2741, Preventing Diabetes in Medicare Act of 2011 and Prediabetes generally; Medicaid coverage of obesity counseling and expanding provider type; Issues related to Medicare Part D and Medicaid rebates as contained in P.L. 112-25 Budget Control Act of 2011 (deficit reduction)
Trans-Pacific Partnership (TPP): biosimilar provisions
S. 1002 SAFE DOSES Act and HR 4223 Safe Doses Act (Modernizing criminal laws concerning theft of medical products)
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), Natl Institutes of Health (NIH), SENATE, White House Office
NOVO NORDISK INC. via NOVO NORDISK INC.
2012 · second_quarter · Q2
S. 3295 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act FY2013 (National Diabetes Prevention Program); Issues related to modernizing cost estimates with respect to preventive health legislation (scoring) and National Diabetes Prevention Program
S. 1002 SAFE DOSES Act and HR 4223 Safe Doses Act (Modernizing criminal laws concerning theft of medical products)
Trans-Pacific Partnership (TPP): biosimilar provisions
P.L. 111-148, Patient Protection and Affordable Care Act of 2009 (ACA) and P.L. 111-152, The Health Care & Education Affordability Reconciliation Act of 2010: biosimilar provisions
P.L. 111-148, Patient Protection and Affordable Care Act of 2009 (ACA) and P.L. 111-152, The Health Care & Education Affordability Reconciliation Act of 2010; CMS Proposed Coverage Decision Memorandum for Intensive Behavioral Therapy for Obesity; Medicare Diabetes Screening; HR 2741, Preventing Diabetes in Medicare Act of 2011 and Prediabetes generally; Medicaid coverage of obesity counseling and expanding provider type; Issues related to Medicare Part D and Medicaid rebates as contained in P.L. 112-25 Budget Control Act of 2011 (deficit reduction)
H.R. 436 Protect Medical Innovation Act of 2011
P.L. 111-148, Patient Protection and Affordable Care Act of 2009 (ACA) and P.L. 111-152, The Health Care & Education Affordability Reconciliation Act of 2010: Issues regarding comparative effectiveness, implementation of Physician Payment Sunshine provisions and Prescription Drug Sample reporting provisions; S.3187 FDA Safety and Innovation Act (PDUFA V); H.R. 4274 Best Pharmaceuticals for Children Act/Pediatric Research Exclusivity Act; H.R. 3026 Safeguarding America's Pharmaceuticals Act of 2011; Pharmaceutical Traceability Enhancement Code (Rx TEC) Act; H.R. 5973 FY2013 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act (FDA funding); 340B
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), Natl Institutes of Health (NIH), SENATE, White House Office
NOVO NORDISK INC. via NOVO NORDISK INC.
2012 · first_quarter · Q1
Supporting increasing funding opportunities for better care and treatment of people with diabetes in P.L. 111-148, Patient Protection and Affordable Care Act of 2009 (ACA) and P.L. 111-152, The Health Care & Education Affordability Reconciliation Act of 2010: Issues related to diabetes generally, and specifically minority health, diabetes screening, National Diabetes Prevention Program, National Prevention Strategy, Medicaid Quality Measures, Medicare Annual Wellness Visit, ACOs (related to Medicare Share Savings Program), Coverage of Preventive Services under ACA, HHS Strategic Plan, HHS Multiple Chronic Conditions Framework, National Quality Strategy, Prevention and Public Health Fund, Diabetes Prevention Issues in a Survey of Primary Care Physicians, Adequate Inclusion of Diabetes Care In the Essential Health Benefits Package, IOM Committee on Valuing Community-based Non-Clinical Prevention Policies and Wellness Strategies, DOL Survey of Employer-Sponsored Health Insurance Coverage, CDC National Survey of Primary Care Policies for Managing Patients with Higher Blood Pressure, High Cholesterol, or Diabetes (NSPCP); H.R. 2954, the Health Equity and Accountability Act of 2011; HR 2960 National Diabetes Clinical Care Commission Act; S. 1559 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act FY2012 on National Diabetes Prevention Program; CMS Obesity Intervention; Healthy People 2020 Abstract; CMS CLIA Program & HIPAA Privacy Rule Patient Access to Test Reports; AHRQ regarding the USPSTF recommendation on screening and management of obesity in adults; PCORI Draft Research Agenda
NOVO NORDISK INC. via NOVO NORDISK INC.
2011 · fourth_quarter · Q4
P.L. 112-29 (H.R. 1249 and S. 23), America Invents Act
P.L. 111-148, Patient Protection and Affordable Care Act of 2009 (ACA) and P.L. 111-152, The Health Care & Education Affordability Reconciliation Act of 2010; CMS Proposed Coverage Decision Memorandum for Intensive Behavioral Therapy for Obesity; Medicare Diabetes Screening; HR 2741, Preventing Diabetes in Medicare Act of 2011 and Prediabetes generally; Issues related to Medicaid rebates and similar revenue provisions as contained in P.L. 112-25, Budget Control Act of 2011 (deficit reduction); HR 3743 Middle Class Tax Relief and Job Creation Act of 2011, HR 3630 Middle Class Tax Relief and Job Creation Act of 2011, and HR 3765 (PL 112-78) Temporary Payroll Tax Cut Continuation of 2011-Issues related to Medicaid rebates and similar revenue provisions
NOVO NORDISK INC. via NOVO NORDISK INC.
2011 · third_quarter · Q3
P.L. 111-148, Patient Protection and Affordable Care Act of 2009 (ACA) and P.L. 111-152, The Health Care & Education Affordability Reconciliation Act of 2010; Deficit reduction and debt ceiling negotiations: Issues related to Medicare Parts B & D, Medicaid rebates and the 340B program, CMS Proposed Coverage Decision Memorandum for Intensive Behavioral Therapy for Obesity
P.L. 111-148, Patient Protection and Affordable Care Act of 2009 (ACA) and P.L. 111-152, The Health Care & Education Affordability Reconciliation Act of 2010: Issues regarding comparative effectiveness, implementation of Physician Payment Sunshine provisions and Prescription Drug Sample transparency reporting provisions; prescription drug reimportation generally; Prescription Drug User Fee Act reauthorization
NOVO NORDISK INC. via NOVO NORDISK INC.
2011 · second_quarter · Q2
H.R. 1473 Department of Defense and Full Year Continuing Appropriations FY11; H.J. Res. 44, Further Continuing Appropriations FY11; H.J. Res. 48, Further Continuing Appropriations FY11; FY12 Budget Resolution: diabetes-related issues and issues related to modernizing cost estimates with respect to preventive health legislation
Supporting increasing funding opportunities for better care and treatment of people with diabetes in P.L. 111-148, Patient Protection and Affordable Care Act of 2009 (ACA) and P.L. 111-152, The Health Care & Education Affordability Reconciliation Act of 2010: Issues related to diabetes generally, and specifically minority health, diabetes screening, National Diabetes Prevention Program, National Prevention Strategy, Medicaid Quality Measures, Medicare Annual Wellness Visit, ACOs (related to Medicare Share Savings Program), Coverage of Preventive Services under ACA, HHS Strategic Plan, HHS Multiple Chronic Conditions Framework, National Quality Strategy, Prevention and Public Health Fund, Diabetes Prevention Issues in a Survey of Primary Care Physicians, and Adequate Inclusion of Diabetes Care In the Essential Health Benefits Package
NOVO NORDISK INC. via NOVO NORDISK INC.
2011 · first_quarter · Q1
H.R. 1249 and S. 23, America Invents Act
Issues related to Medicaid rebates and similar revenue provisions as contained in P.L. 111-148, Patient Protection and Affordable Care Act of 2009 (ACA); P.L. 111-152, The Health Care & Education Affordability Reconciliation Act of 2010: issues related to the 340B program
Modernizing criminal laws concerning theft of medical products
NOVO NORDISK INC. via NOVO NORDISK INC.
2010 · fourth_quarter · Q4
H. Con. Res. 85, S. Con. Res. 13, and H.R. 4851, Continuing Extension Act of 2010; P.L. 111-148, Patient Protection and Affordable Care Act of 2009; P.L. 111-152, The Health Care & Education Affordability Reconciliation Act of 2010; issues regarding comparative effectiveness
H.R. 1260 and S. 515, Patent Reform Act of 2009, entire bill; H.R. 1408, Sunshine in Litigation Act
H.R. 1995, S. 844, Eliminating Disparities in Diabetes Prevention Access and Care Act and the Diabetes in Minority Populations Evaluations Act; H.R. 3090, Health Equity and Accountability Act; P.L. 111-148, Patient Protection and Affordable Care Act of 2009; P.L. 111-152, The Health Care & Education Affordability Reconciliation Act of 2010, issues related to minority health
NOVO NORDISK INC. via NOVO NORDISK INC.
2010 · third_quarter · Q3
H.R. 1260 and S. 515, Patent Reform Act of 2009, entire bill; H.R. 1408, Sunshine in Litigation Act
H.R. 3148, the Preventive Health Savings Act
H.R. 759, FDA Globalization Act; S. 301, Physician Payments Sunshine Act of 2009
NOVO NORDISK INC. via NOVO NORDISK INC.
2009 · fourth_quarter · Q4
Issues related to Medicaid rebates, Public Health Service Act programs, and other revenue provisions contained in H.R. 3200, and H.R. 3926, Affordable Health Care for America Act, H.R. 3590, Patient Protection and Affordable Care Act, S. 1796, America's Healthy Future Act of 2009
H.R. 1402, S. 1473, the Catalyst for Better Diabetes Care Act; H.R. 2590, Preventing Diabetes in Medicare Act; H.R. 2425, Medicare Diabetes Self-Management Training Act; H.R. 3200 and H.R. 3926, Affordable Health Care for America Act, H.R. 3590, Patient Protection and Affordable Care Act, and S. 1796, America's Healthy Future Act of 2009, diabetes provisions
FY12 Budget Resolution and FY13 Appropriations: diabetes-related issues and issues related to modernizing cost estimates with respect to preventive health legislation and National Diabetes Prevention Program HR 2608 (PL 112-36) Continuing Appropriations Act, 2012; HJ RES 94 (PL 112-67); CR through 12/17/11; HJ RES 95 (PL 112-68) CR through 12/23/11; P.L. 112-74 Consolidated Appropriations Act of 2012 on National Diabetes Prevention Program
H.R. 436 Protect Medical Innovation Act of 2011
S. 1002 SAFE DOSES Act and HR 4223 Safe Doses Act (Modernizing criminal laws concerning theft of medical products)
P.L. 111-148, Patient Protection and Affordable Care Act of 2009 (ACA) and P.L. 111-152, The Health Care & Education Affordability Reconciliation Act of 2010; CMS Proposed Coverage Decision Memorandum for Intensive Behavioral Therapy for Obesity; Medicare Diabetes Screening; HR 2741, Preventing Diabetes in Medicare Act of 2011 and Prediabetes generally; Issues related to Medicaid rebates and similar revenue provisions as contained in P.L. 112-25, Budget Control Act of 2011 (deficit reduction); HR 3743 Middle Class Tax Relief and Job Creation Act of 2011, HR 3630 Middle Class Tax Relief and Job Creation Act of 2011, and HR 3765 (PL 112-78) Temporary Payroll Tax Cut Continuation of 2011-Issues related to Medicaid rebates and similar revenue provisions; Medicaid coverage of obesity counseling and expanding provider type.
P.L. 111-148, Patient Protection and Affordable Care Act of 2009 (ACA) and P.L. 111-152, The Health Care & Education Affordability Reconciliation Act of 2010: Issues regarding comparative effectiveness, implementation of Physician Payment Sunshine provisions and Prescription Drug Sample reporting provisions; HR 2112 FY12 Agriculture, Commerce/State/Justice, Transportation, & HUD Appropriations on prescription drug reimportation; Prescription Drug User Fee Act reauthorization Best Pharmaceuticals for Children Act/Pediatric Research Exclusivity Act; Supply Chain safety; Pharmaceutical Traceability Enhancement Code (Rx TEC) Act
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), Natl Institutes of Health (NIH), SENATE, White House Office
P.L. 111-148, Patient Protection and Affordable Care Act of 2009 (ACA) and P.L. 111-152, The Health Care & Education Affordability Reconciliation Act of 2010: Issues regarding comparative effectiveness, implementation of Physician Payment Sunshine provisions and Prescription Drug Sample reporting provisions; HR 2112 FY12 Agriculture, Commerce/State/Justice, Transportation, & HUD Appropriations on prescription drug reimportation; Prescription Drug User Fee Act reauthorization
FY12 Budget Resolution: diabetes-related issues and issues related to modernizing cost estimates with respect to preventive health legislation; HR 2608 (PL 112-36) Continuing Appropriations Act, 2012; HJ RES 94 (PL 112-67); CR through 12/17/11; HJ RES 95 (PL 112-68) CR through 12/23/11; P.L. 112-74 Consolidated Appropriations Act of 2012 on National Diabetes Prevention Program
Supporting increasing funding opportunities for better care and treatment of people with diabetes in P.L. 111-148, Patient Protection and Affordable Care Act of 2009 (ACA) and P.L. 111-152, The Health Care & Education Affordability Reconciliation Act of 2010: Issues related to diabetes generally, and specifically minority health, diabetes screening, National Diabetes Prevention Program, National Prevention Strategy, Medicaid Quality Measures, Medicare Annual Wellness Visit, ACOs (related to Medicare Share Savings Program), Coverage of Preventive Services under ACA, HHS Strategic Plan, HHS Multiple Chronic Conditions Framework, National Quality Strategy, Prevention and Public Health Fund, Diabetes Prevention Issues in a Survey of Primary Care Physicians, Adequate Inclusion of Diabetes Care In the Essential Health Benefits Package, IOM Committee on Valuing Community-based Non-Clinical Prevention Policies and Wellness Strategies, DOL Survey of Employer-Sponsored Health Insurance Coverage, CDC National Survey of Primary Care Policies for Managing Patients with Higher Blood Pressure, High Cholesterol, or Diabetes (NSPCP); H.R. 2954, the Health Equity and Accountability Act of 2011; HR 2960 National Diabetes Clinical Care Commission Act; S. 1559 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act FY2012 on National Diabetes Prevention Program; CMS Obesity Intervention; Healthy People 2020 Abstract; CMS CLIA Program & HIPAA Privacy Rule Patient Access to Test Reports; AHRQ regarding the USPSTF recommendation on screening and management of obesity in adults
H.R. 436 Protect Medical Innovation Act of 2011
S. 1002 SAFE DOSES Act (Modernizing criminal laws concerning theft of medical products)
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), Natl Institutes of Health (NIH), SENATE, White House Office
H.R. 1473 Department of Defense and Full Year Continuing Appropriations FY11; H.J. Res. 44, Further Continuing Appropriations FY11; H.J. Res. 48, Further Continuing Appropriations FY11; FY12 Budget Resolution: diabetes-related issues and issues related to modernizing cost estimates with respect to preventive health legislation
H.R. 436 Protect Medical Innovation Act of 2011
Supporting increasing funding opportunities for better care and treatment of people with diabetes in P.L. 111-148, Patient Protection and Affordable Care Act of 2009 (ACA) and P.L. 111-152, The Health Care & Education Affordability Reconciliation Act of 2010: Issues related to diabetes generally, and specifically minority health, diabetes screening, National Diabetes Prevention Program, National Prevention Strategy, Medicaid Quality Measures, Medicare Annual Wellness Visit, ACOs (related to Medicare Share Savings Program), Coverage of Preventive Services under ACA, HHS Strategic Plan, HHS Multiple Chronic Conditions Framework, National Quality Strategy, Prevention and Public Health Fund, Diabetes Prevention Issues in a Survey of Primary Care Physicians, Adequate Inclusion of Diabetes Care In the Essential Health Benefits Package, IOM Committee on Valuing Community-based Non-Clinical Prevention Policies and Wellness Strategies, DOL Survey of Employer-Sponsored Health Insurance Coverage, CDC National Survey of Primary Care Policies for Managing Patients with Higher Blood Pressure, High Cholesterol, or Diabetes (NSPCP); H.R. 2954, the Health Equity and Accountability Act of 2011; HR 2960 National Diabetes Clinical Care Commission Act; S. 1559 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act FY2012
H.R. 1249 and S. 23, America Invents Act
S. 1002 SAFE DOSES Act (Modernizing criminal laws concerning theft of medical products)
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), Natl Institutes of Health (NIH), SENATE
H.R. 1249 and S. 23, America Invents Act
P.L. 111-148, Patient Protection and Affordable Care Act of 2009 (ACA) and P.L. 111-152, The Health Care & Education Affordability Reconciliation Act of 2010: Issues regarding comparative effectiveness, implementation of Physician Payment Sunshine provisions and Prescription Drug Sample transparency reporting provisions; prescription drug reimportation generally; Prescription Drug User Fee Act reauthorization
H.R. 436 Protect Medical Innovation Act of 2011
S. 1002 SAFE DOSES Act (Modernizing criminal laws concerning theft of medical products)
P.L. 111-148, Patient Protection and Affordable Care Act of 2009 (ACA) and P.L. 111-152, The Health Care & Education Affordability Reconciliation Act of 2010; Deficit reduction and debt ceiling negotiations: Issues related to Medicare Parts B & D, Medicaid rebates and the 340B program.
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Justice, Dept of (DOJ), Natl Institutes of Health (NIH), SENATE
Supporting increasing funding opportunities for better care and treatment of people with diabetes in P.L. 111-148, Patient Protection and Affordable Care Act of 2009 (ACA) and P.L. 111-152, The Health Care & Education Affordability Reconciliation Act of 2010: Issues related to diabetes generally, and specifically minority health, diabetes screening, National Diabetes Prevention Program, National Prevention Strategy, Medicaid Quality Measures, Medicare Annual Wellness Visit, ACOs (related to Medicare Share Savings Program), Coverage of Preventive Services under ACA, HHS Strategic Plan, HHS Multiple Chronic Conditions Framework, National Quality Strategy, and the Prevention and Public Health Fund
H.R. 1, Full Year Continuing Appropriations FY11; H.J. Res. 44, Further Continuing Appropriations FY11; H.J. Res. 48, Further Continuing Appropriations FY11; FY12 Budget Resolution: diabetes-related issues and issues related to modernizing cost estimates with respect to preventive health legislation
P.L. 111-148, Patient Protection and Affordable Care Act of 2009 (ACA); P.L. 111-152, The Health Care & Education Affordability Reconciliation Act of 2010: Issues regarding comparative effectiveness, Prescription Drug User Fee Act reauthorization, prescription drug reimportation generally, implementation of Physician Payment Sunshine provisions and Prescription Drug Sample transparency reporting provisions
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Issues related to Medicaid rebates and similar revenue provisions as contained in P.L. 111-148, Patient Protection and Affordable Care Act of 2009; P.L. 111-152, The Health Care & Education Affordability Reconciliation Act of 2010; H.R. 4213, American Jobs and Closing Tax Loopholes Act of 2010, and S. 3793, Jobs Creation and Tax Cut Act; and H.R. 3081, Continuing Appropriations Act 2011, issues related to the 340(b) program
H.R. 3148, the Preventive Health Savings Act; H.R. 3663 and S. 3058, To amend the Public Health Service Act to reauthorize the special diabetes programs for Type I diabetes and Indians under that Act; S. 3686 Labor, Health and Human Services, and Education Appropriations Act, 2011, diabetes-related provisions
H.R. 5175 and S. 3628, Democracy is Strengthened by Casting Light on Spending in Elections (DISCLOSE) Act
H.R. 4853 (P.L. 111-312) Tax Relief, Unemployment Insurance Reauthorization, and Job Creation Act of 2010
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), Patent & Trademark Office (PTO), SENATE
Issues related to Medicaid rebates and similar revenue provisions as contained in P.L. 111-148, Patient Protection and Affordable Care Act of 2009; P.L. 111-152, The Health Care & Education Affordability Reconciliation Act of 2010; H.R. 4213, American Jobs and Closing Tax Loopholes Act of 2010, and S. 3793, Jobs Creation and Tax Cut Act, and H.R. 3081, Continuing Appropriations Act 2011, issues related to the 340(b) program
Supporting increasing funding opportunities for better care and treatment of people with diabetes in P.L. 111-148, Patient Protection and Affordable Care Act of 2009; P.L. 111-152, The Health Care & Education Affordability Reconciliation Act of 2010, including National Diabetes Prevetion Program, National Quality Strategy, and Public Health Fund
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), Patent & Trademark Office (PTO), SENATE
H.R. 3148, the Preventive Health Savings Act; S. 1796, America's Healthy Future Act of 2009 and H.R. 3590, Patient Protection and Affordable Care Act, scoring provisions
H.R. 759, FDA Globalization Act; S. 301, Physician Payments Sunshine Act of 2009, issues related to federal preemption; H.R. 2502, Comparative Effectiveness Research Act of 2009; S. 1213, Patient-Centered Outcomes Research Act of 2009
H.R. 1260 and S. 515, Patent Reform Act of 2009, entire bill
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), Patent & Trademark Office (PTO), SENATE